000 | 01823 a2200469 4500 | ||
---|---|---|---|
005 | 20250516190947.0 | ||
264 | 0 | _c20140926 | |
008 | 201409s 0 0 eng d | ||
022 | _a1521-009X | ||
024 | 7 |
_a10.1124/dmd.113.054932 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEnglund, Gunilla | |
245 | 0 | 0 |
_aCytochrome p450 inhibitory properties of common efflux transporter inhibitors. _h[electronic resource] |
260 |
_bDrug metabolism and disposition: the biological fate of chemicals _cMar 2014 |
||
300 |
_a441-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xantagonists & inhibitors |
650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily G, Member 2 |
650 | 0 | 4 |
_aATP-Binding Cassette Transporters _xantagonists & inhibitors |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aCryopreservation |
650 | 0 | 4 | _aCytochrome P-450 Enzyme Inhibitors |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHepatocytes _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMicrosomes, Liver _xdrug effects |
650 | 0 | 4 |
_aMultidrug Resistance-Associated Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aNeoplasm Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aPharmaceutical Preparations _xchemistry |
650 | 0 | 4 | _aSubstrate Specificity |
700 | 1 | _aLundquist, Patrik | |
700 | 1 | _aSkogastierna, Cristine | |
700 | 1 | _aJohansson, Jenny | |
700 | 1 | _aHoogstraate, Janet | |
700 | 1 | _aAfzelius, Lovisa | |
700 | 1 | _aAndersson, Tommy B | |
700 | 1 | _aProjean, Denis | |
773 | 0 |
_tDrug metabolism and disposition: the biological fate of chemicals _gvol. 42 _gno. 3 _gp. 441-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1124/dmd.113.054932 _zAvailable from publisher's website |
999 |
_c23422574 _d23422574 |